MedTrace Logo

Prospective Cohort Study With Central Nervous System Evaluation in Diffuse Large B-cell Lymphoma

NCT01202448 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2015-03-03

No results posted yet for this study

Summary

This study is to evaluate the incidence of central nervous system (CNS) relapse or metastasis in patients with diffuse large B-cell lymphoma.

Conditions

  • Diffuse Large B-cell Lymphoma

Interventions

PROCEDURE

CSF analysis

The cerebrospinal fluid will be evaluated via lumbar puncture.

Sponsors & Collaborators

  • Asan Medical Center

    collaborator OTHER

  • Yonsei University

    collaborator OTHER

  • National Cancer Center, Korea

    collaborator OTHER_GOV

  • Korea Cancer Center Hospital

    collaborator OTHER

  • Korea University

    collaborator OTHER

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Cheolwon Suh, MD, PhD · Consortium for Improving Survival of Lymphoma

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2015-02-28
Completion
2015-02-28

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01202448 on ClinicalTrials.gov